Adicet Bio, Inc. — Director's Dealing 2019

Dec 6, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: resTORbio, Inc. (TORC)
CIK: 0001720580
Period of Report: 2019-12-06

Reporting Person: Mannick Joan (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-06	Common Stock	A	118222	$0.00	Acquired	1404585	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-06	Stock Option (Right to Buy)	$1.27	A	88667	Acquired	2029-12-05	Common Stock (88667)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	600000	Indirect

Footnotes

F1: The Reporting Person was issued Restricted Stock Units ("RSU"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest in four (4) annual installments, with the first tranche vesting on December 6, 2020. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.

F2: Shares held by the J.B. Mannick Irrevocable Trust (the "Trust"). The reporting person disclaims Section 16 beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose

F3: 25% of the shares shall vest on December 6, 2020, with the remainder vesting in 36 equal monthly installments thereafter.